TechNet-21 - Forum

This forum provides a place for members to ask questions, share experiences, coordinate activities, and discuss recent developments in immunization.

Discussions tagged Policy and legislation

Upcoming webinar on VVM-based vaccine management - January 21st @ 4pm CET

Please join us for a webinar on vaccine vial monitor (VVM)-based vaccine management, on the occasion of publishing of “The Book of VVM: Yesterday-today-and-tomorrow” by Umit Kartoglu. The webinar will take place on Tuesday, January 21st at 4pm CET. During the webinar, the presenters will discuss the critical role of VVM in vaccine management policies as well as the VVM shaping the future of the (digitized) cold chain. The presenters will be: Umit Kartoglu, Co-founder and CEO, Extensio et Progressio, Collonge-Bellerive, Switzerland (author of The Book of VVM) Debbie Kristensen, Director of Vaccine Technology, Strategy, and Policy / Medical Devices and Health Technologies, PATH, Geneva, Switzerland Ted Prusik, Co-founder and Senior Vice President, Temptime Corporation, Morris Plains, NJ, USA For presenter biographies, refer to the attached document. It is not an overstatement to say that VVM is one of the most important recent innovations in the area of public health, providing health workers with advisable and dependable means of ensuring that the administered vaccine has not been damaged by heat. Amongst all the temperature monitoring devices and tools, VVM is the only one that has dramatically changed the course of vaccine management practices as well as shaped the future of the cold chain. Some critical approaches we have today in vaccine management have only been made possible with the help of VVM, and others have been made more effective. For a quick review of VVM-induced vaccine management policies and VVM based vaccine management, refer to pages 201 and 245 in The Book of VVM (free download in PDF and ePUB3 formats from http://kartoglu.ch/vvm). Registration at: https://who-meeting.webex.com/who-meeting/onstage/g.php?MTID=e27289500ca959052459c45ec0e2540e1

Recommendations from SAGE Oct 2019 - published today- Data Use and Quality highlighted

WER with recommendations from SAGE Oct 2019 was published today (attached). Below I highlight two areas related to immunization data use and quality. Enjoy the reading, Carolina “[Immunization Agenda 20330] IA2030 envisions a world in which “everyone, everywhere, at every age, fully benefits from vaccines for good health and well-being”. To achieve this vision, a balance is struck between a disease-specific and a systems approach, with commitment to existing goals for eradication and elimination, new goals for the next decade and alignment as closely as possible with the GVAP review. The 7 strategic priorities of the IA2030 framework are: 1) immunization for primary health care and universal health coverage, 2) commitment and demand, 3) coverage and equity, 4) life-course and integration, 5) outbreaks and emergencies, 6) supply and sustainability and 7) research and innovation. These priorities will be achieved on the basis of 4 core principles: people-focused, country-owned, partnership-based and data-enabled” __________________________________ “SAGE endorsed the following recommendations: Embed monitoring of data quality into global, regional and national monitoring of the surveillance of immunization and [vaccine-preventable diseases] VPDs. Increase the capacity and capability of the workforce for ensuring data quality and use, starting at the level at which data are collected. Improve the accuracy of denominators. Enhance use of all available data for tailored action, including programme planning, management and decision-making. Adopt a data-driven continuous quality improvement approach as part of health system strengthening at all levels. Strengthen governance of the pilot-testing and use of new tools for collection and use of immunization and surveillance data. Improve data-sharing and knowledge management among areas and organizations for greater transparency and efficiency. WHO and UNICEF should strengthen global reporting and data monitoring through a periodic needs assessment and revision process. These recommendations should be added to the IA2030, and regions and countries should include multi-component interventions for improving data quality and use in their regional 2021–2030 strategies. These recommendations should also be integrated into the broader efforts of [Universal Health Coverage] UHC and [Primary Health Care] PHC.”
  • Page :
  • 1